Form 4 for VKTX Viking Therapeutics, Inc.
Accepted 2023-03-30 00:00:00 ET · period of report 2023-03-28 · accession 0001209191-23-021743 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-30 | 2023-03-28+ | VKTX | Mancini Marianna | COO | S - Sale+OE | $15.17 | -237.8K | 288.1K | -45% | -$3.61M |
| DM | 2023-03-30 | 2023-03-28+ | VKTX | Mancini Marianna | COO | M - OptEx | $2.93 | +182.4K | 337.1K | +118% | +$534.1K |
| DM | 2023-03-30 | 2023-03-28+ | VKTX | Mancini Marianna | COO | M - OptEx | $0.00 | -182.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 per share | 2023-03-29 | S | D | 41,242 | $16.00 | 261,895 | D | — | — | |
| 2 | Common | Common Stock, par value $0.00001 per share | 2023-03-29 | M | A | 15,000 | $9.13 | 303,137 | D | — | — | |
| 3 | Common | Common Stock, par value $0.00001 per share | 2023-03-28 | S | D | 196,563 | $15.00 | 288,137 | D | — | — | |
| 4 | Common | Common Stock, par value $0.00001 per share | 2023-03-28 | M | A | 30,000 | $4.37 | 484,700 | D | — | — | |
| 5 | Common | Common Stock, par value $0.00001 per share | 2023-03-28 | M | A | 24,500 | $4.65 | 454,700 | D | — | — | |
| 6 | Common | Common Stock, par value $0.00001 per share | 2023-03-28 | M | A | 15,000 | $1.26 | 352,146 | D | — | — | |
| 7 | Common | Common Stock, par value $0.00001 per share | 2023-03-28 | M | A | 15,000 | $1.08 | 420,200 | D | — | — | |
| 8 | Common | Common Stock, par value $0.00001 per share | 2023-03-28 | M | A | 53,054 | $1.23 | 405,200 | D | — | — | |
| 9 | Common | Common Stock, par value $0.00001 per share | 2023-03-28 | M | A | 15,000 | $2.15 | 332,273 | D | — | — | |
| 10 | Common | Common Stock, par value $0.00001 per share | 2023-03-28 | M | A | 10,000 | $1.04 | 430,200 | D | — | — | |
| 11 | Common | Common Stock, par value $0.00001 per share | 2023-03-28 | M | A | 4,873 | $1.88 | 337,146 | D | — | — | |
| 12 | Derivative | Stock Option (right to buy) | 2023-03-29 | M | D | 15,000 | $0.00 | 0 | D | $9.13 · 2016-05-21 to 2025-05-21 | 15,000 Common Stock | (F2) 25% of the shares subject to the option vested on each one year anniversary of the grant date. |
| 13 | Derivative | Stock Option (right to buy) | 2023-03-28 | M | D | 30,000 | $0.00 | 0 | D | $4.37 · 2019-03-30 to 2028-03-30 | 30,000 Common Stock | (F5) One-third of the shares subject to the option vested on each one year anniversary of the grant date. |
| 14 | Derivative | Stock Option (right to buy) | 2023-03-28 | M | D | 24,500 | $0.00 | 0 | D | $4.65 · 2019-01-19 to 2028-01-19 | 24,500 Common Stock | (F2) 25% of the shares subject to the option vested on each one year anniversary of the grant date. |
| 15 | Derivative | Stock Option (right to buy) | 2023-03-28 | M | D | 10,000 | $0.00 | 0 | D | $1.04 · 2018-08-31 to 2027-08-31 | 10,000 Common Stock | (F2) 25% of the shares subject to the option vested on each one year anniversary of the grant date. |
| 16 | Derivative | Stock Option (right to buy) | 2023-03-28 | M | D | 15,000 | $0.00 | 0 | D | $1.08 · 2018-06-30 to 2027-06-30 | 15,000 Common Stock | (F2) 25% of the shares subject to the option vested on each one year anniversary of the grant date. |
| 17 | Derivative | Stock Option (right to buy) | 2023-03-28 | M | D | 15,000 | $0.00 | 0 | D | $1.26 · 2017-06-30 to 2026-06-30 | 15,000 Common Stock | (F2) 25% of the shares subject to the option vested on each one year anniversary of the grant date. |
| 18 | Derivative | Stock Option (right to buy) | 2023-03-28 | M | D | 4,873 | $0.00 | 0 | D | $1.88 · 2016-03-14 to 2026-03-14 | 4,873 Common Stock | (F3) The shares subject to the option vested on the grant date. |
| 19 | Derivative | Stock Option (right to buy) | 2023-03-28 | M | D | 15,000 | $0.00 | 0 | D | $2.15 · 2017-03-04 to 2026-03-04 | 15,000 Common Stock | (F2) 25% of the shares subject to the option vested on each one year anniversary of the grant date. |
| 20 | Derivative | Stock Option (right to buy) | 2023-03-28 | M | D | 53,054 | $0.00 | 0 | D | $1.23 · 2017-01-05 to 2027-01-05 | 53,054 Common Stock | (F4) 23,054 shares vested on the grant date of 01/05/2017 and 25% of the remaining 30,000 shares subject to the option vested on each one year anniversary of the grant date. |